Archive · 18 Nov 2025
Psychedelic Therapy Shows Promise in Easing Terminal Patients' Anxiety
Scientists found that using special mushrooms (psilocybin) with talking to a therapist can help people with cancer feel less scared and more happy about dying.
Some people had amazing experiences that helped them feel better.
Other countries are doing more research on this, but the UK is going slower because of strict rules about drugs.
A big talk in the government about how to help people who are dying is making people think about using these mushrooms to help.
Psychedelic therapy, using psilocybin with psychotherapy, reduced depression and anxiety in cancer patients.
Participants reported improved mood, emotional clarity, and reduced fear of death.
Some described profound experiences of emotional release, awe, and connection.
UK lags behind other countries in psychedelic research due to strict drug regulations.
End-of-life bill debate sparks conversation about psychedelic therapy's potential role.
- Who
- Patients with life-threatening cancer, researchers, governments, and the public
- What
- Psychedelic therapy using psilocybin with psychotherapy
- When
- Currently, with research ongoing and policy debates happening
- Where
- Around the world, with UK lagging behind
- Why
- To help patients cope with anxiety, depression, and existential distress related to dying
Proponents of Psychedelic Therapy
Skeptics and Regulatory Bodies
Access to Treatment
Proponents of Psychedelic Therapy
Psychedelic therapy should be more accessible for terminal patients to ease their suffering.
Skeptics and Regulatory Bodies
Strict regulations are necessary to prevent misuse and ensure safety.
Research Funding
Proponents of Psychedelic Therapy
More funding should be allocated for research to explore psychedelic therapy's potential.
Skeptics and Regulatory Bodies
Current regulations make research slow and costly, discouraging innovation.
- Psychedelic Substance
- Psilocybin
- Duration of Effects
- Up to six months
- Countries Leading Research
- Australia, Germany, Canada, EU
- UK's Drug Classification
- Class A (substances of little or no medicinal value)
- UK's End-of-Life Bill
- Currently being debated in parliament